Author Correction: Simultaneous downregulation of miR-21 and upregulation of miR-7 has anti-tumor efficacy

• Deepak Bhere,
• Nahid Arghiani,
• Esther Revai Lechtich,
• Yizheng Yao,
• Sarah Alsaab,
• Fengfeng Bei,
• Maryam M. Matin,
• Khalid Shah

Affiliations

Deepak Bhere

Center for Stem Cell Therapeutics and Imaging (CSTI), Brigham and Women’s Hospital, Harvard Medical School

Nahid Arghiani

Center for Stem Cell Therapeutics and Imaging (CSTI), Brigham and Women’s Hospital, Harvard Medical School

Esther Revai Lechtich

Center for Stem Cell Therapeutics and Imaging (CSTI), Brigham and Women’s Hospital, Harvard Medical School

Yizheng Yao

Department of Neurosurgery, Brigham and Women’s Hospital, Harvard Medical School

Sarah Alsaab

Center for Stem Cell Therapeutics and Imaging (CSTI), Brigham and Women’s Hospital, Harvard Medical School

Fengfeng Bei

Department of Neurosurgery, Brigham and Women’s Hospital, Harvard Medical School

Maryam M. Matin

Department of Biology and Institute of Biotechnology, Ferdowsi University of Mashhad

Khalid Shah

Center for Stem Cell Therapeutics and Imaging (CSTI), Brigham and Women’s Hospital, Harvard Medical School